Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 7, 2026
Reporting Period: Preliminary unaudited results for the three-month period and fiscal year ended December 31, 2025.
Key Financial Metrics
The filing references a press release (Exhibit 99.1) containing preliminary net sales results for the quarter and full year ended December 31, 2025. However, the text of this Form 8-K does not provide specific numerical values for:
- Revenue (Net Sales)
- Profit or Net Income
- Cash Flow
- Profit Margins
- Debt Levels
- Liquidity Metrics
Note: Specific financial figures are not present in the provided filing text and must be sourced from the referenced Exhibit 99.1.
Material Changes
The filing text does not explicitly detail material changes versus prior comparable periods. It only confirms the issuance of preliminary results for the 2025 fiscal year and quarter.
Guidance, Outlook, and Management Commentary
Guidance: The press release included preliminary guidance for certain financial measures for the fiscal year ending December 31, 2026. Specific targets or ranges are not listed in this document.
Management Commentary: The report is signed by Kyle Kline, Chief Financial Officer. No specific commentary on risks, contingencies, or unusual items is included in the body of this Form 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 7, 2026) for actual net sales figures for Q4 and FY 2025.
- Verify the specific preliminary guidance metrics for fiscal year 2026 provided in the press release.
- Confirm if the preliminary results include any restatements or adjustments to prior periods.
- Check for any non-GAAP reconciliations or explanations of unusual items in the full press release.